6th Circ. Won't Rehear Generic-Reglan Injury Claims

By Kira Lerner (January 24, 2014, 6:42 PM EST) -- The Sixth Circuit refused to rehear seven lawsuits alleging drug manufacturers should be liable for serious neurological conditions that users incurred after taking a generic version of digestion medication Reglan, finding Thursday that the users' claims have already been considered.

The appeals court declined to reconsider its December decision to uphold a lower court's ruling, which dismissed the cases because the plaintiffs had taken metoclopramide, the generic name for Reglan, and brand-name manufacturers couldn't be held liable under the Tennessee Products Liability Act for injuries from products they didn't make.

Thursday's brief order said that the petition for rehearing was circulated...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!